Skip to content
Screener

Heron Therapeutics HRTX Q2 2025 earnings

Reported August 8, 2025 · After market close

Revenue$37.2MMiss by $1.9M
EPS-$0.02Miss by $0.01
Revenue estimate$39.1M
EPS estimate-$0.01

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$37.5M
EPS estimate-$0.03

FAQ

When did Heron Therapeutics report Q2 2025 earnings?
Heron Therapeutics (HRTX) reported Q2 2025 earnings on August 8, 2025 after market close.
What were Heron Therapeutics's Q2 2025 revenue and EPS?
Heron Therapeutics reported revenue of $37.2M and eps of $-0.02 for Q2 2025.
Did Heron Therapeutics beat estimates in Q2 2025?
Revenue missed the consensus estimate of $39.1M by $1.9M. EPS missed the consensus estimate of $-0.01 by $0.01.
How did Heron Therapeutics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 3.3% from $36.0M a year earlier and eps grew 66.7% from $-0.06.
Where can I find Heron Therapeutics's Q2 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-105474) and the 10-Q periodic report (0000950170-25-105475) directly on SEC EDGAR. The filing index links above go to sec.gov.